Table 4.
Predictive score for predicting recurrent disease
| Factors | Score | |
|---|---|---|
| Overall Populationa | EGFRb | |
| CEA | ||
| < 3.8 ng/ml | 0 | 0 |
| ≥ 3.8 ng/ml | 2 | 3 |
| pT | ||
| pT1/2a | 0 | 0 |
| pT2b | 1 | 1 |
| pT3 | 2 | 1 |
| pT4 | 18 | 34 |
| pN | ||
| pN0 | 0 | 0 |
| pN1 | 4 | 4 |
| pN2 | 6 | 6 |
| Margin | ||
| Negative | 0 | 0 |
| Positive | 2 | 39 |
| LVI | ||
| Negative | 0 | |
| Positive | 1 | |
| Pleural invasion | ||
| Negative | 0 | 0 |
| Positive | 1 | 2 |
| Histology subtype | ||
| Lepidic | 0 | |
| Acinar | 1 | |
| Micropapillary | 1 | |
| Papillary | 4 | |
| Solid | 2 | |
| Mucinous | 3 | |
pT pathological tumor stage, pN pathological nodal stage, LVI Lymphovascular invasion
aCut-off ≥ 6 with sensitivity of 63% and specificity 86% ROC
bCut-off ≥ 5 with sensitivity of 62% and specificity 93% ROC